Sierra Oncology logo
Sierra Oncology SRRA
$ 54.89 -0.05%

Quarterly report 2022-Q1
added 12-16-2023

report update icon

Sierra Oncology Income Statement 2011-2024 | SRRA

Annual Income Statement Sierra Oncology

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

288 M 167 M 1.59 B 3.74 B 7.44 B 1.65 B 4.77 B - - - -

Shares

13.3 M 10.4 M 2.91 M 1.77 M 1.25 M 756 K 360 K - - - -

Historical Prices

21.7 16 547 2.11 K 5.97 K 2.38 K 24.1 K - - - -

Net Income

-94.7 M -80.9 M -88.3 M -53.3 M -42 M -47.9 M -53.3 M -23.9 M -6.83 M - -

Revenue

- 300 K - - - - - - - - -

Cost of Revenue

- - - - - - - - - - -

Gross Profit

- 300 - - - - - - - - -

Operating Income

-94.6 M -64.9 M -67 M -55.4 M -42.6 M -48.1 M -35.8 M -22.6 M -4 M - -

Interest Expense

-77 K 421 K -517 K 1.78 M 760 K 351 K 66 K 87 K 2.72 M - -

EBITDA

-94.3 M -64.7 M -66.9 M -55.3 M -42.4 M -47.9 M -35.7 M -22.5 M -3.91 M - -

Operating Expenses

94.6 M 65.2 M 67 M 55.4 M 42.6 M 48.1 M 35.8 M - - - -

General and Administrative Expenses

27.4 M 20.1 M 13.7 M 14.3 M 12.5 M 14.2 M 9.47 M 3.5 M 1.16 M - -

All numbers in USD currency

Quarterly Income Statement Sierra Oncology

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - 21 M 15.6 M 13.7 M 12.4 M 11.7 M 11.1 M 10.4 M 10.4 M 10.2 M 1.87 M 1.87 M 1.87 M 1.86 M 1.86 M 74.3 M 74.3 M 59.7 M 52.4 M 52.3 M 52.3 M 42.6 M 30.4 M 30.3 M 30.2 M 30.1 M 30.1 M 24.2 M 1.5 M 1.49 M 1.59 M 1.02 M 920 K - - - - - - - - - - - - -

Net Income

- - - -27.9 M - -28.6 M -20.6 M -19.9 M -18 M -14.5 M -16.5 M -31.9 M -47.5 M -12.9 M -14.9 M -13 M -14.3 M -15.6 M -12 M -11.5 M -10.6 M -10 M -10.3 M -11.1 M -9.25 M -15.2 M -12.9 M -10.5 M -11.5 M -53.3 M -53.3 M -53.3 M -3.62 M -3.96 M -13.8 M -2.47 M - - - - - - - - - - - -

Revenue

- - - - - - - - 200 K 100 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - -27.9 M - -28.6 M -20.6 M -19.8 M - -14.4 M -16.4 M -16.1 M - -13.3 M -15.2 M -13.5 M - -16.1 M -13 M -11.8 M - -10.2 M -10.5 M -11.2 M - -15.3 M -12.9 M -10.6 M - -11 M -6.61 M -6.74 M - -3.48 M -13.5 M - - - - - - - - - - - - -

Interest Expense

- - - -59 K - 3 K 48 K -29 K - -22 K 24 K 541 K - 288 K 348 K 325 K - 479 K 582 K 272 K - 225 K 185 K 96 K - 88 K 88 K 83 K - 29 K -6 K 25 K - 22 K 31 K - - - - - - - - - - - - -

EBITDA

- - - -27.8 M - -28.6 M -20.6 M -19.8 M - -14.3 M -16.3 M -16.1 M - -13.1 M -15.1 M -13.4 M - -16 M -12.9 M -11.7 M - -10.1 M -10.4 M -11.1 M - -15.2 M -12.9 M -10.6 M - -11 M -6.59 M -6.72 M - -3.48 M -13.5 M - - - - - - - - - - - - -

Operating Expenses

- - - 27.9 M - 28.6 M 20.6 M 19.8 M 18.1 M 14.5 M 16.4 M 16.1 M 25 M 13.3 M 15.2 M 13.5 M 14.6 M 16.1 M 13 M 11.8 M 10.8 M 10.2 M 10.5 M 11.2 M 9.23 M 15.3 M 12.9 M 10.6 M 11.4 M 11 M 6.61 M 6.74 M 3.27 M 3.48 M 13.5 M 2.32 M - - - - - - - - - - - -

General and Administrative Expenses

- - - 10.3 M - 6.98 M 6.42 M 5.86 M - 4.11 M 6.26 M 4.54 M - 3.15 M 3.48 M 3.36 M - 3.14 M 4.18 M 3.42 M - 2.78 M 3.28 M 3.15 M - 2.96 M 3.83 M 3.98 M - 2.74 M 1.87 M 1.44 M - 1.04 M 791 K - - - - - - - - - - - - -

All numbers in USD currency